Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis
Clinical trial NCT01848041 · COMPLETED
Trial details
- NCT number
- NCT01848041
- Sponsor
- RVL Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-01-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.